Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy NanoViricides stock

Learn how to easily invest in NanoViricides stock.

NanoViricides is a biotechnology business based in the US. NanoViricides shares (NNVC) are listed on the NYSE MKT and all prices are listed in US Dollars. NanoViricides employs 17 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy NanoViricides stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – NNVC. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance



  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

NanoViricides stock price (NYSE MKT: NNVC)

Use our graph to track the performance of NNVC stocks over time.

NanoViricides shares at a glance

Information last updated 2023-01-25.
Latest market close$1.45
52-week range$1.04 - $3.88
50-day moving average $1.45
200-day moving average $1.82
Wall St. target price$8.50
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.73

Buy NanoViricides stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy NanoViricides stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NanoViricides price performance over time

Historical closes compared with the close of $1.45 from 2023-01-26

1 week (2023-01-20) 3.57%
1 month (2022-12-27) 28.32%
3 months (2022-10-28) -12.12%
6 months (2022-07-28) -20.33%
1 year (2022-01-28) -32.87%
2 years (2021-01-28) -61.33%
3 years (2020-01-28) 8.4
5 years (2018-01-26) 46.42%

NanoViricides financials

Gross profit TTM $0
Return on assets TTM -17.37%
Return on equity TTM -28.33%
Profit margin 0%
Book value $1.86
Market capitalisation $16.4 million

TTM: trailing 12 months

NanoViricides share dividends

We're not expecting NanoViricides to pay a dividend over the next 12 months.

Have NanoViricides's shares ever split?

NanoViricides's shares were split on a 1:20 basis on 23 September 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NanoViricides shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NanoViricides shares which in turn could have impacted NanoViricides's share price.

NanoViricides share price volatility

Over the last 12 months, NanoViricides's shares have ranged in value from as little as $1.04 up to $3.88. A popular way to gauge a stock's volatility is its "beta".

NNVC.US volatility(beta: 1.07)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NanoViricides's is 1.068. This would suggest that NanoViricides's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

NanoViricides overview

NanoViricides, Inc. , a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut. .

Frequently asked questions

What percentage of NanoViricides is owned by insiders or institutions?
Currently 4.4% of NanoViricides shares are held by insiders and 11.334% by institutions.
How many people work for NanoViricides?
Latest data suggests 17 work at NanoViricides.
When does the fiscal year end for NanoViricides?
NanoViricides's fiscal year ends in June.
Where is NanoViricides based?
NanoViricides's address is: 1 Controls Drive, Shelton, CT, United States, 06484
What is NanoViricides's ISIN number?
NanoViricides's international securities identification number is: US6300873022
What is NanoViricides's CUSIP number?
NanoViricides's Committee on Uniform Securities Identification Procedures number is: 630087302

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site